Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China-Reference-Cited by-同舟云学术

Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China

Published:2014-01-29 Issue:9 Volume:120 Page:1353-1360
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ji Ming-Fang¹,Huang Qi-Hong²,Yu Xia¹,Liu Zhiwei³,Li Xinghua¹,Zhang Li-Fang⁴,Wang Panpan¹,Xie Shang-Hang⁴,Rao Hui-Lan⁵,Fang Fang³,Guo Xiang⁶,Liu Qing⁴,Hong Ming-Huang⁷,Ye Weimin³,Zeng Yi-Xin⁸,Cao Su-Mei⁴

Affiliation:

1. Cancer Research Institute of Zhongshan City; Zhongshan City Guangdong Province China

2. Sihui Cancer Institute; Sihui Guangdong Province China

3. Department of Medical Epidemiology and Biostatistics; Karolinska Institute; Stockholm Sweden

4. Department of Cancer Prevention Research, Cancer Prevention Center, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Guangdong Province China

5. Department of Pathology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Guangdong Province China

6. Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Guangdong Province China

7. Clinical Trail Study Center, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Guangdong Province China

8. Department of Experimental Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Guangdong Province China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin.,2005

2. A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma [article in Chinese];Mao;Ai Zheng.,2009

3. Epstein-Barr viral antigens used in the diagnosis of nasopharyngeal carcinoma;Gan;J Biomed Sci.,1996

4. Use of bacterially expressed EBNA-1 protein cloned from a nasopharyngeal carcinoma (NPC) biopsy as a screening test for NPC patients;Chen;J Med Virol.,2001

5. Detection of anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus;Joab;J Infect Dis.,1991

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization and Local Cost-Effectiveness of Nasopharyngeal Carcinoma Screening Strategies in Southern China: Secondary Analysis of the Guangdong Randomized Trial;Cancer Epidemiology, Biomarkers & Prevention;2024-05-02

2. Plasma Epstein-Barr virus microRNA BART8-3p as a potential biomarker for detection and prognostic prediction in early nasopharyngeal carcinoma;Scientific Reports;2024-03-28

3. Early detection of nasopharyngeal carcinoma through machine‐learning‐driven prediction model in a population‐based healthcare record database;Cancer Medicine;2024-03-28

4. Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma;BMC Cancer;2023-12-09

5. Early screening of nasopharyngeal carcinoma;Head & Neck;2023-08-08